home / stock / absi / absi news


ABSI News and Press, Absci Corporation

Stock Information

Company Name: Absci Corporation
Stock Symbol: ABSI
Market: NASDAQ
Website: absci.com

Menu

ABSI ABSI Quote ABSI Short ABSI News ABSI Articles ABSI Message Board
Get ABSI Alerts

News, Short Squeeze, Breakout and More Instantly...

ABSI - Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships

2024-07-28 01:24:46 ET Summary Absci Corporation uses IDCP technology to quickly produce high-quality drug candidates in as little as six weeks, reducing costs and improving research success rates. The company has promising candidates in inflammatory bowel disease, dermatology, an...

ABSI - Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

VANCOUVER, Wash. and NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for the second quarter after market close on Wednesday,...

ABSI - Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, Wash. and NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced that on July 1, 2024, the company granted a non-statutory stock option to purchase an aggregate of 613,000 shares of its common stoc...

ABSI - Morgan Stanley starts Absci at overweight, cites AI theme

2024-07-03 10:51:31 ET More on Absci Absci: 'AI' Tag Keeping Company Afloat While Searching For Right Formula Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Absci Historical earnings data for Absci Fin...

ABSI - Absci to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit

VANCOUVER, Wash. and NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Morgan Stanley 3 rd Annual Life Sciences AI Summit on June 26-27 in New York, ...

ABSI - Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

VANCOUVER, Wash. and NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Goldman Sachs 45 th Annual Global Healthcare Conference in Miami, FL. Absci...

ABSI - PLAB, ARRY and SYM are among after hour movers

2024-05-24 16:58:54 ET Gainers: Photronics ( PLAB ) +6% . Replimune Group  ( REPL ) +4% . Caribou Biosciences ( CRBU ) +3% . Symbotic  ( SYM ) +3% . Arhaus ( ARHS ) +3% . Losers: OneMedNet  ( ONMD ) -...

ABSI - ASTS, CRBU and DOMO are among after hour movers

2024-05-23 16:47:49 ET Gainers: Ross Stores ( ROST ) +6% . Frontier Group Holdings ( ULCC ) +4% . Caribou Biosciences ( CRBU ) +4% . Absci Corporation ( ABSI ) +3% . Protara Therapeutics ( TARA ) +3% . Losers: Domo ( DO...

ABSI - Absci: 'AI' Tag Keeping Company Afloat While Searching For Right Formula

2024-05-16 18:36:07 ET Summary Absci Corporation, an AI-driven drug discovery company, has seen its share price plummet after its IPO in July 2021. Nearly all AI-driven drug discovery companies have struggled with overall share price performance since IPO. Absci's stock has be...

ABSI - Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript

2024-05-14 13:30:24 ET Absci Corporation. (ABSI) Q1 2024 Earnings Conference Call May 14, 2024 8:30 AM ET Company Participants Alex Khan – Vice President, Finance and Investor Relations Sean McClain – Founder and Chief Executive Officer Zach Jonasso...

Next 10